A Novel Oral Antiviral Drug for Covid-19. Can It Make a Difference?

Authors

  • Moizza Tahir Associate Professor Dermatology Combined Military Hospital Gwadar/ National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v73i1.7652

Keywords:

Oral Antiviral Drug, COVID-19, COVID Treatment

Abstract

Countries across the world are striving to vaccinate their citizens against the virus that brings about COVID-19. Not only developed countries but also developing ones have had success in vaccinating a huge number of people. Advance and improved treatments are still required to reduce hospitalizations and deaths. They also aid in the prevention of virus propagation. It is important to recognize that, despite being vaccinated, there is still a need for alternative and more effective COVID treatment options. In the quest to create a solution for battling COVID-19, antiviral medicine was developed. The good thing about this solution is that it can be taken orally rather than intravenously which can be provided outside of a hospital setting before COVID-19 has progressed to a critical level. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

07-03-2023

How to Cite

Tahir, M. (2023). A Novel Oral Antiviral Drug for Covid-19. Can It Make a Difference?. Pakistan Armed Forces Medical Journal, 73(1), 317. https://doi.org/10.51253/pafmj.v73i1.7652

Issue

Section

Letter to the Editor

Most read articles by the same author(s)

1 2 > >>